[{"address1": "400 Fifth Avenue", "address2": "Suite 210", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "510 745 1700", "website": "https://www.ardelyx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 395, "companyOfficers": [{"maxAge": 1, "name": "Mr. Michael G. Raab", "age": 59, "title": "President, CEO & Director", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 1271044, "exercisedValue": 897400, "unexercisedValue": 4020738}, {"maxAge": 1, "name": "Mr. Justin A. Renz CPA, MBA", "age": 52, "title": "Chief Financial & Operations Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 734970, "exercisedValue": 0, "unexercisedValue": 667291}, {"maxAge": 1, "name": "Ms. Elizabeth A. Grammer Esq.", "age": 60, "title": "Chief Legal & Administrative Officer and Secretary", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 724423, "exercisedValue": 1601636, "unexercisedValue": 532996}, {"maxAge": 1, "name": "Dr. Laura A. Williams M.D., M.P.H.", "age": 61, "title": "Chief Patient Officer", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 739126, "exercisedValue": 669900, "unexercisedValue": 606994}, {"maxAge": 1, "name": "Mr. Mike  Kelliher", "age": 47, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 622498, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph  Reilly", "age": 50, "title": "Senior VP of Finance & Principal Accounting Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caitlin  Lowie", "title": "Vice President of Corporate Communications & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James P. Brady", "title": "Chief Human Resources Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David P. Rosenbaum Ph.D.", "age": 63, "title": "Head of Drug Discovery and Early Development", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 645400, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric Duane Foster", "age": 49, "title": "Chief Commercial Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 5, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.19, "open": 4.22, "dayLow": 4.17, "dayHigh": 4.315, "regularMarketPreviousClose": 4.19, "regularMarketOpen": 4.22, "regularMarketDayLow": 4.17, "regularMarketDayHigh": 4.315, "payoutRatio": 0.0, "beta": 0.592, "forwardPE": -61.0, "volume": 2838474, "regularMarketVolume": 2838474, "averageVolume": 5432049, "averageVolume10days": 4167660, "averageDailyVolume10Day": 4167660, "bid": 3.04, "ask": 5.37, "bidSize": 2, "askSize": 2, "marketCap": 1021618880, "fiftyTwoWeekLow": 3.21, "fiftyTwoWeekHigh": 7.18, "priceToSalesTrailing12Months": 2.8244457, "fiftyDayAverage": 3.9833, "twoHundredDayAverage": 5.060325, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 905558400, "profitMargins": -0.14863, "floatShares": 218916126, "sharesOutstanding": 239255008, "sharesShort": 27283637, "sharesShortPriorMonth": 27769893, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.11399999, "heldPercentInsiders": 0.02513, "heldPercentInstitutions": 0.72463, "shortRatio": 5.39, "shortPercentOfFloat": 0.1292, "impliedSharesOutstanding": 239255008, "bookValue": 0.609, "priceToBook": 7.0114937, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -53762000, "trailingEps": -0.23, "forwardEps": -0.07, "enterpriseToRevenue": 2.504, "enterpriseToEbitda": -24.219, "52WeekChange": -0.21651375, "SandP52WeekChange": 0.12677538, "quoteType": "EQUITY", "currentPrice": 4.27, "targetHighPrice": 15.0, "targetLowPrice": 8.0, "targetMeanPrice": 10.72727, "targetMedianPrice": 10.0, "recommendationMean": 1.41667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 213952000, "totalCashPerShare": 0.894, "ebitda": -37391000, "totalDebt": 181630000, "quickRatio": 3.434, "currentRatio": 4.123, "totalRevenue": 361705984, "debtToEquity": 124.681, "revenuePerShare": 1.529, "returnOnAssets": -0.065809995, "returnOnEquity": -0.36256, "grossProfits": 249299008, "freeCashflow": -17224376, "operatingCashflow": -47544000, "revenueGrowth": 0.61, "grossMargins": 0.68922997, "ebitdaMargins": -0.103369996, "operatingMargins": -0.49045, "financialCurrency": "USD", "symbol": "ARDX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Ardelyx, Inc.", "epsTrailingTwelveMonths": -0.23, "epsForward": -0.07, "epsCurrentYear": -0.43987, "priceEpsCurrentYear": -9.707414, "fiftyDayAverageChange": 0.2867, "fiftyDayAverageChangePercent": 0.0719755, "twoHundredDayAverageChange": -0.79032516, "twoHundredDayAverageChangePercent": -0.15618071, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "longName": "Ardelyx, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1403184600000, "postMarketChangePercent": 1.1498811, "postMarketPrice": 4.3191, "postMarketChange": 0.049099922, "regularMarketChange": 0.0799999, "regularMarketDayRange": "4.17 - 4.315", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 5432049, "fiftyTwoWeekLowChange": 1.06, "fiftyTwoWeekLowChangePercent": 0.33021805, "fiftyTwoWeekRange": "3.21 - 7.18", "fiftyTwoWeekHighChange": -2.9099998, "fiftyTwoWeekHighChangePercent": -0.40529248, "fiftyTwoWeekChangePercent": -21.651375, "earningsTimestamp": 1746129711, "earningsTimestampStart": 1753992000, "earningsTimestampEnd": 1753992000, "earningsCallTimestampStart": 1746131400, "earningsCallTimestampEnd": 1746131400, "isEarningsDateEstimate": true, "corporateActions": [], "postMarketTime": 1751575552, "regularMarketTime": 1751562001, "exchange": "NGM", "messageBoardId": "finmb_58915635", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.90931, "regularMarketPrice": 4.27, "marketState": "CLOSED", "displayName": "Ardelyx", "trailingPegRatio": null, "__fetch_time": "2025-07-05"}]